nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone phenpropionate—AR—duct of salivary gland—head and neck cancer	0.598	0.769	CbGeAlD
Nandrolone phenpropionate—CYP19A1—connective tissue—head and neck cancer	0.0275	0.0354	CbGeAlD
Nandrolone phenpropionate—AR—connective tissue—head and neck cancer	0.0244	0.0313	CbGeAlD
Nandrolone phenpropionate—AR—epithelium—head and neck cancer	0.0231	0.0298	CbGeAlD
Nandrolone phenpropionate—CYP19A1—thyroid gland—head and neck cancer	0.0183	0.0235	CbGeAlD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—AREG—head and neck cancer	0.0179	0.0806	CbGpPWpGaD
Nandrolone phenpropionate—AR—lymphoid tissue—head and neck cancer	0.0178	0.0229	CbGeAlD
Nandrolone phenpropionate—CYP19A1—head—head and neck cancer	0.0162	0.0209	CbGeAlD
Nandrolone phenpropionate—AR—thyroid gland—head and neck cancer	0.0162	0.0208	CbGeAlD
Nandrolone phenpropionate—AR—head—head and neck cancer	0.0144	0.0185	CbGeAlD
Nandrolone phenpropionate—AR—Nuclear Receptors—RARB—head and neck cancer	0.0138	0.0622	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—CEBPA—head and neck cancer	0.0136	0.0613	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—lymph node—head and neck cancer	0.0114	0.0146	CbGeAlD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—RARB—head and neck cancer	0.0109	0.0491	CbGpPWpGaD
Nandrolone phenpropionate—AR—lymph node—head and neck cancer	0.0101	0.0129	CbGeAlD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—XRCC3—head and neck cancer	0.00661	0.0298	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—XRCC3—head and neck cancer	0.00569	0.0256	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00522	0.0235	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—NOTCH1—head and neck cancer	0.00478	0.0215	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00422	0.019	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—RAD51—head and neck cancer	0.00417	0.0188	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00417	0.0188	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—NAT2—head and neck cancer	0.00388	0.0175	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—NAT2—head and neck cancer	0.00383	0.0172	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.0038	0.0171	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—MAPK3—head and neck cancer	0.00369	0.0166	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—RAD51—head and neck cancer	0.00359	0.0161	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—MAPK3—head and neck cancer	0.00354	0.016	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CASP8—head and neck cancer	0.00353	0.0159	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—MAPK1—head and neck cancer	0.00351	0.0158	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.00345	0.0155	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00342	0.0154	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—MAPK1—head and neck cancer	0.00337	0.0152	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—PIK3CA—head and neck cancer	0.00305	0.0137	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—HRAS—head and neck cancer	0.00282	0.0127	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—head and neck cancer	0.00281	0.0126	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—STAT3—head and neck cancer	0.00277	0.0125	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CCND1—head and neck cancer	0.0026	0.0117	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—AKT1—head and neck cancer	0.00249	0.0112	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—AKT1—head and neck cancer	0.00239	0.0108	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—head and neck cancer	0.00209	0.00943	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.00207	0.00933	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CCND1—head and neck cancer	0.00192	0.00866	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTM1—head and neck cancer	0.00192	0.00863	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—GSTM1—head and neck cancer	0.00189	0.00852	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—RARB—head and neck cancer	0.00189	0.00849	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—PTEN—head and neck cancer	0.00186	0.00836	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP1A1—head and neck cancer	0.00182	0.00818	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00179	0.00807	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—YAP1—head and neck cancer	0.00172	0.00772	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.00171	0.0077	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.00169	0.00761	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—STAT3—head and neck cancer	0.00166	0.00747	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—UROD—head and neck cancer	0.0016	0.0072	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—EGFR—head and neck cancer	0.00151	0.00679	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.00147	0.00663	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.00147	0.00661	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.00145	0.00655	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—AKT1—head and neck cancer	0.00145	0.00652	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.00142	0.00638	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.00126	0.00569	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.00126	0.00567	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.00124	0.00559	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.00122	0.00548	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.00122	0.00547	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.00116	0.0052	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.00115	0.00519	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.0011	0.00495	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.00108	0.00488	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.00107	0.00482	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—AKT1—head and neck cancer	0.00107	0.00482	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.00105	0.00471	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.00104	0.0047	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.00101	0.00454	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000989	0.00445	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000989	0.00445	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000945	0.00426	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.00091	0.0041	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—RARB—head and neck cancer	0.000908	0.00409	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000861	0.00388	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000851	0.00383	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000851	0.00383	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.00083	0.00374	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—YAP1—head and neck cancer	0.000826	0.00372	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000819	0.00369	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000819	0.00369	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000773	0.00348	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000714	0.00322	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000711	0.0032	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000705	0.00317	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000701	0.00316	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000698	0.00314	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000688	0.0031	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NAT2—head and neck cancer	0.000664	0.00299	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000603	0.00271	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—DPYD—head and neck cancer	0.000582	0.00262	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000581	0.00261	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—YAP1—head and neck cancer	0.000553	0.00249	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000415	0.00187	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NOTCH1—head and neck cancer	0.000372	0.00168	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000362	0.00163	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TYMS—head and neck cancer	0.000332	0.00149	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTM1—head and neck cancer	0.000328	0.00148	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GPX1—head and neck cancer	0.000314	0.00141	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP1A1—head and neck cancer	0.000311	0.0014	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000255	0.00115	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—MAPK3—head and neck cancer	0.000206	0.000927	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTGS2—head and neck cancer	0.000185	0.000832	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTEN—head and neck cancer	0.000161	0.000726	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—AKT1—head and neck cancer	0.000139	0.000625	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CA—head and neck cancer	0.000114	0.000512	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—AKT1—head and neck cancer	9.29e-05	0.000418	CbGpPWpGaD
